Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(1.90)
# 3,098
Out of 4,893 analysts
381
Total ratings
33.77%
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALT Altimmune | Reiterates: Buy | $12 | $4.74 | +153.16% | 18 | Jun 27, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $2.58 | +287.60% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $0.75 | +566.67% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.53 | +1,800.78% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.48 | +1,057.41% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $34.60 | +189.02% | 21 | Jun 2, 2025 | |
| QURE uniQure | Reiterates: Buy | $70 | $14.87 | +370.75% | 15 | May 29, 2025 | |
| ONCY Oncolytics Biotech | Reiterates: Buy | $5 | $1.20 | +316.67% | 18 | May 21, 2025 | |
| DTIL Precision BioSciences | Reiterates: Buy | $60 | $4.73 | +1,168.50% | 18 | May 21, 2025 | |
| ATAI Atai Life Sciences | Reiterates: Buy | $10 | $2.66 | +275.94% | 19 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $18.88 | +323.73% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $3.53 | +1,174.79% | 15 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $15.48 | +158.40% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.47 | +764.55% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $34.29 | +104.14% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $21.46 | +272.79% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $320.87 | +55.83% | 26 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $2.40 | +316.67% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.36 | +635.29% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $7.72 | +612.44% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $5.93 | +1,754.97% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $26.58 | +219.79% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $7.52 | +1,894.68% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $13.76 | +394.19% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $309.62 | +9.81% | 1 | Aug 18, 2021 |
Altimmune
Jun 27, 2025
Reiterates: Buy
Price Target: $12
Current: $4.74
Upside: +153.16%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $2.58
Upside: +287.60%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $0.75
Upside: +566.67%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.53
Upside: +1,800.78%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.48
Upside: +1,057.41%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $34.60
Upside: +189.02%
uniQure
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $14.87
Upside: +370.75%
Oncolytics Biotech
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.20
Upside: +316.67%
Precision BioSciences
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.73
Upside: +1,168.50%
Atai Life Sciences
May 20, 2025
Reiterates: Buy
Price Target: $10
Current: $2.66
Upside: +275.94%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $18.88
Upside: +323.73%
May 12, 2025
Reiterates: Buy
Price Target: $45
Current: $3.53
Upside: +1,174.79%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $15.48
Upside: +158.40%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $3.47
Upside: +764.55%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $34.29
Upside: +104.14%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $21.46
Upside: +272.79%
Apr 2, 2025
Reiterates: Buy
Price Target: $500
Current: $320.87
Upside: +55.83%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $2.40
Upside: +316.67%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $1.36
Upside: +635.29%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $7.72
Upside: +612.44%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $5.93
Upside: +1,754.97%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $26.58
Upside: +219.79%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $7.52
Upside: +1,894.68%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $13.76
Upside: +394.19%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $309.62
Upside: +9.81%